We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

ProImmune Introduces ProT2 MHC Class II Tetramer Reagents

Product News   Jan 14, 2016

 
ProImmune Introduces ProT2 MHC Class II Tetramer Reagents
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

PerkinElmer Expands Cell Biology Leadership

Product News

PerkinElmer, Inc. has announced that it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The transaction is expected to close during the second quarter of 2021.

READ MORE

FDA Approves Orgenesis IDE for Pilot Clinical Trial of its Tissue Genesis Icellator2(R)

Product News

Orgenesis Inc. announces it has been granted Investigational Device Exemption (IDE) approval by the United States Food and Drug Administration (FDA) to conduct a first-in-human feasibility study of the Tissue Genesis Icellator2(R) to treat Acute Respiratory Distress Syndrome (ARDS) resulting from COVID-19 infection.

READ MORE

Thermo Fisher Scientific Launches GMP- and Cleanroom-Compatible CO2 Incubator

Product News

Thermo Fisher Scientific has launched a first-in-market CO2 incubator that combines optimal cell growth capabilities with certified cleanroom compatibility, effectively addressing the growing need among biotechnology, biopharmaceutical and clinical laboratories for high-performance incubation systems that meet stringent cleanroom and cGMP standards.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE